Novartis is reimagining medicine to improve and extend people's lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world's top companies investing in research and development. Novartis products reach nearly 1 billion people globally and we are finding innovative ways to expand access to our latest treatments. About 125 000 people of more than 140 nationalities work at Novartis around the world.
- Focus : Manufacturer
- Employees: 10,001+
- Industry : Pharma
News about Novartis
05-May-2021 | manufacturing
BASF strengthens its global production footprint for enzymes
BASF will invest at Novartis’ Kundl/Schaftenau Campus, in Austria
05-Mar-2021 | manufacturing
CureVac and Novartis Sign Initial Agreement on Manufacturing of COVID-19 Vaccine Candidate, CVnCoV
Anticipated production of up to 50 million doses by the end of 2021 and up to a further 200 million doses in 2022 at the Novartis’ manufacturing site in Kundl, Austria
29-Jul-2020 | business & finance
Sandoz announces plans for joint investment to help strengthen future of antibiotics manufacturing in Europe
Sandoz, the Novartis generics and biosimilars division, is pleased to announce plans for a joint investment, together with the Austrian federal government ...
25-Apr-2019 | business & finance
Novartis to invest $75 million in start-up Poseida
Poseida Therapeutics Raises $142 Million in Series C Financing
14-Mar-2019 | people
Novartis announces change in Sandoz leadership
Novartis announced that Richard Francis will be stepping down as CEO of Sandoz, a Novartis division, and as a member of the Executive Committee of Novartis ...
03-Sep-2018 | science
Fraunhofer IZI and Novartis Continue Collaboration with CAR-T Cell Therapy
Novartis and Fraunhofer IZI announced that a further agreement has been concluded between Novartis and the Fraunhofer Institute for Cell Therapy and ...
27-Mar-2018 | business & finance
Novartis to sell stake in consumer healthcare joint venture to GSK
Focussing on strategic priorities